TipRanks
AbbVie (DE:4AB)
XETRA:4AB

Compare AbbVie (4AB) vs. Competitors

27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
AbbVie
€221.50
€427.11B
76.75
19.55%
20 Buy
4 Hold
0 Sell
Strong Buy
Amgen
$442.24
$223.32B
25.12
38.29%
9 Buy
16 Hold
2 Sell
Moderate Buy
Bristol-Myers Squibb
$64.72
$121.95B
13.12
33.77%
8 Buy
12 Hold
1 Sell
Moderate Buy
Johnson & Johnson
$273.14
$622.84B
29.65
35.21%
14 Buy
4 Hold
0 Sell
Strong Buy
Merck & Company
$156.45
$352.29B
113.01
64.79%
14 Buy
7 Hold
0 Sell
Moderate Buy
Pfizer
$28.57
$159.59B
36.76
8.33%
8 Buy
14 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:4AB
AbbVie
237.90
42.96
22.04%
AMGN
Amgen
407.44
119.99
41.74%
BMY
Bristol-Myers Squibb
59.58
16.80
39.28%
JNJ
Johnson & Johnson
256.48
69.61
37.25%
MRK
Merck & Company
142.38
57.38
67.50%
PFE
Pfizer
27.82
4.23
17.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts